Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Your comments are incorrect. The tests must be functional ina clinical setting and this is where is is at. Thaey have to gather clinical information, no longer blind samples. It will take time.
Greed is what always destroys all that is good. They haven't closed any additional licensees, not because there aren't interested partners, but because they are quibbling over minor details. Meanwhile, if we don't close a deal this year and Wittenberg issues himself more shares I will personally lose what little faith I have left in what is right and just in this world. Sign the contracts and let's move on to bigger and better things.
Dr Moro is dreaming of finding a cure which will happen if he understood that compromises during negotiations are necessary. He never anticipated Abbott taking so long and was forced to make a deal with a hedge fund that 1)is shorting the stock 2)is getting 100,000 dollars a month in payments 3)will have warrants attached for 1.5 million shares at .60 cents when the share price is above 1.20, and another 3 million shares at 1.20. I am seriously concerned about the dilution of stock.
What ever happened to the publication in Tumor Biology? The SB-2 has clearly defined boundaries with information in regards to Abbott. Dr Moro is effectively disallowed to make mention of any progress they are making. That is why it is so important to close the deals on the table. This will revive the faith especially with me.
I have noticed for quite some time that the Biocurex website under the subheading investors, that the information and statistics related to cancer are from 2002. This alerts any new investors that management has been lazy and has not updated this site for over 5 years. Either remove this or update it. It shows a lack of interest by management to update their website.
That letter should be sent to all of the cancer research centers.
I am humbled by your dedication towards benefiting others. I am sure I speak for everyone when I say thank you for your initiative. God bless.
I respectfully disagree. If Dr Moro had not attended any of the scientific meetings he would have no one to collaborate with (meaning no samples to test), no contract with Abbott, and no one in discussions for potential licensing. Their method of buying publicity has only caused dilution, liquidation at any price, and has caused the share price to be where it is today. Reread the interview with Dr Moro and Erthang. Dr Moro's quoted as saying that after the announcement of the Abbott deal we were well over 2 dollars and now we are closer than ever to commercialization and the share price is significantly lower and he was baffled by this. He is a doctor and so is Wittenberg and they have failed to see the damage of giving away shares which should have had a lockup period of several years. The slap in the face is the same people he entrusted to promote the company to elevate the share price were exactly the one's that have caused the share price to tumble to these levels. They never should have issued unrestricted shares on a stock that has the ability to move in any direction by more than 10% on a few thousand shares. This is not a liquid stock.
You seem to have forgotten Dr Moro has moved on from diagnostics, because the test IS ready.
It is an objective view of Dr Wittenberg's performance and his report card when the share price has declined significantly. Would you give your money to a money manager and 2 1/2 years later see he lost 75% of your hard hard earned money. Would you allow him to continue to manage your money? That's what you are saying by being complacent in regards to his performance. If he isn't ultimately responsible, who is?
If you call Biocurex you will see Dr Wittenberg is practicing dentistry and not at any office in Biocurex or at the lab. This is not a witch hunt, but he is ultimately responsible for the substantial loss of share price since closing the Abbott agreement. Dr Moro please put friendship aside and focus on what will be best for the future of our company. Also please continue to attend more scientific meetings that is the best way to add credibility, and make the company legit by filing under Biocurex not Whispering Oaks. By the way, I am of the knowledge they read this board.
This stock is a penny stock because there is a failure to communicate. They have all the right ingredients for success. It turns my stomach to know they fail to recognize this. We have left no stone unturned as far as I'm concerned in investigating their past mistakes by management. The conclusion is in concensus we need a true leader with a proven track record to lead this company forward, and Biocurex should no longer be submitting under a horse racing company. Check out the SB-2 under their previous filings with the SEC. It lays out ALL the details of the Abbott deal. They are wasting time not signing any deals and we have the competition on our heals as well as patent expirations. Contact Canada's Health Commissioner right NOW and tell them about the billions of dollars you will save them by fast tracking Recaf. Stop wasting precious time and losing my money with the stock price continuing to fall. Put the peddle to the metal and get the job done for heaven's sake, and start doing what you have originally intended to do.......SAVE LIVES.
Instead of giving Wittenberg millions of shares of stock I would rather see a reputable leader with a history of accomplishments not failures. He may have served a purpose for Dr Moro 5 years ago to get the company listed, but now he is raping the company. No one would argue his worth if he wasn't paying for daytrading penny newsletters and the share price was reflective of its real worth. I just can't get past the fact he is still practicing dentistry.
Don't forget the fact that Dr Wittenberg is still practicing dentistry. This is a side job. That to me is criminal, and we are all paying his salary. It is like being taxed 50% a year, because he gets equal shares to Dr Moro. We definitely can change this if there is enough shareholders to make it happen. I have always for quite a long time expressed the need for a true leader with experience in biotech to take us in the right direction . Again, the share price is his report card and I give it a failing grade.
There is definitely good news on the horizon, just watch the share price, that has always been a valid indicator in the past. There were alot of buyers at .70 cents today. As we all know, Abbott has applied for a patent on Recaf on their Architect system for lung cancer. Probably, because there are no valid markers for lung cancer and this will get the attention of medical community. We all focus on prostrate, but forget this is a universal marker.
Terry is a good guy, and he has always returned my calls. Thank you G-G for calling. You will hear from him.
I did call. There is alot going on behind the scenes and his explanation is that Dr Moro is very cognizant of the anticipation by shareholders, but he is very careful not to divulge information which is not acceptable to the terms of their agreement with Abbott or upcoming agreements. There is absolutely no concerns as far the hedge fund. Also, the party involved in selling shares did a private placement and as Gold said it only gives them a window of time where they can possibly sell, but does not mean they are definitely selling. There is always readjustments made to one's portfolio toward the end of the year for tax purposes. It is reassuring when you speak to Terry, and he welcomes any calls from shareholders. IMO, we will be rewarded soon. He is forwarding an email to Dr Moro that shareholders are getting restless. The more calls the faster we will get our wish.
Call TOLLFREE: 1(866)884-8669. Let's all turn this ship and help guide management in the right direction, because apparently they have lost sight of the fact that they have shareholders to contend with.
If management is legally bound not to speak about Abbott explain this to shareholders. There is a lack of communication which is presenting a problem reflective in the stock price. Please call today. Let's send them a message loud and clear that we are all upset with the lack of information.
Here we are all on the same page and I know we all have the same questions and concerns. Isn't it sad that we are asking Gold to answer our questions? I really feel that we will get the proper response if we all call tomorrow. Please all of you make the effort I know you won't regret it.
If you agree, please call on Monday. They don't know how bad it's gotten. There will be an update if enough of us call on Monday, mark my words. Don't forget that they are on Pacific time.
The problem is that you have Dr Wittenberg practicing dentistry and Dr Moro micromanaging to save money and he does not understand there are investors that cannot possibly know what is going on behind the scenes. I respect that he is totally focused on his work, but he forgets that just because he is pleased with his progress, he has lost focus on his bread and butter...the shareholders. Again, if it weren't for this website many would have bailed on this stock before the meeting not knowing that we were even going to be there. They only said something after. We were at .45 cents at that time,and the share price moved up only because Gold pieced it togetherand shared his findings with all of us here. Don't tell me there is nothing wrong with that. They are screwing up and that is reflective in the share price. I can only hope that someone at Biocurex reads this board and will get the message they are not in my good graces at this time. It is definitely time for an update. Last time I called and bitched we saw a response shortly thereafter. I will call. I encourage EVERYONE to call if you truly care about your investment or expect more of the same. There must be some kind of interaction with them. You can be anonymous, just say you are a shareholder, and want to know when we will have an update.
I know in the past when there were shareholder updates it had a very positive effect, and restores confidence.
I respectfully disagree. We have a patented product and I have been invested over 4 years with this company. I am also very emotional about this company, but this is an investment. This chatroom has been the most effective tool for the success of Biocurex, and to me that says alot. It tells me we are all starving for information and we all turn to this chatroom for answers. What was so secretive there wasn't a press release about Dr Moro attending the ISOBM to the shareholders BEFORE the meeting? Why was it that we are the only ones in the know, only because of the work of a select few. I was told there are over 4,000 shareholders and there is no way that they all know about this chatroom, so they rely on press releases for their information.
I want this company to be successful, so I take it personal that there is a lack of communication.
How can you count on any income when there hasn't even been a PMA application? Believe me I've been checking. If I was in management I would set a meeting with Abbott and find out what they plan to do with Recaf now that they are sure that it definitely works better than any diagnostic cancer test available. Let's hope management will regroup with a better gameplan instead of being so passive about the future.
I am afraid there is intent by Abbott to delay intentionally for their benefit in hopes of us running out of money. They are naive to think they got our back. There are billions of dollars at stake.
I would hope that by the end of the month we will be informed of any new progress.
I would like to see them hire a director from a major biotech company with experience to get us on a better path. The share price is management's report card. We have settled in at a floor of .70 cents which in my mind is disgusting. There is too much of a disconnect between the current share price and what Dr Moro has accomplished. He should be all over Dr Wittenberg and give him an ultimatum. Dr Moro has done everything right and as of yet he nor the shareholders have been justly rewarded. Something has to change to take us to the next level.
Gold, I told Terry about Constabpharma several weeks ago and he said he relayed an email to Dr Moro and they would be checking into possible patent infringement, I was more interested in a collaboration or buying them out at some point, obviously when we have money. They are also a Canadian company. The response is that Dr Moro was aware of their progress and would not rule out something with them.
Is it me or is this just more of the same. No follow up, more dilution, wasting money on penny newsletters, low volume, and share price drifting lower. We need to know when the company will expect Recaf to hit the market. It is time for a shareholder update if management has any consideration for its shareholders.
I am disappointed in no real media coverage. We have something exclusive and something everyone in the world would be intersted in knowing about. What is so hard about picking up the phone and bombarding the media. I am so angry they are still making the same mistakes and need to put an end to paying for coverage and absolutely no effort to contact any media. This is a major failure to execute properly by management and I am afraid they will never understand the share price is where it is at, because of their failure to take the high road. Anyone I have personally told about Biocurex has always asked me if they are on the stock exchange and was excited about the technology.
I will continue to be patient, but I won't feel management has done its job until I see us presenting at more oncology meetings and have unpaid for media coverage. There is nothing wrong with an update about Abbott, the ISOBM, or any negotiations. They must have their heads way up their *** if they don't realize everyone is suffering monetarily as a result of their waste of money issuing shares to small cap as they continue to sell. I would rather have them spend the money on hiring more employees or a newer facility for our lab.
As far as Biocurexman, my interpretation of "uh oh" meant he finally saw the data was corroborated by Abbott and he screwed up by selling his shares too early. He gave up on this stock, but still was curious after all the time he invested in this company and was still drawn to this chat room.
There is a perception that many things are going on behind the scenes, but "SHOW ME THE MONEY!!!!!!" There are too many competitors and it is time to tell the world what Biocurex has discovered. I want to see us at every cancer meeting. There are two roads to take to get the public and investors informed, so far they have only taken the low road by spending shareholder money and diluting the stock with penny newsletters. If anyone employed from Biocurex is curious what shareholders think and chime into this board out of curiosity which in the past appears to be the case, it is your moral duty to properly serve your shareholders, and as a large shareholder I personally would wish you would allow Terry to inform the media. We were waiting for independant verification and we got it. What are you waiting for. I continuously google biomarkers for most every cancer, but you have discovered "The Holy Grail," the only universal cancer marker. Let's let the media know and reward all of your patient shareholders, as well as save many lives. Dr Moro is deserving of the Nobel Peace Prize and it is a sad shame he hasn't received his just due. The share price will inevidably take care of itself once the world knows this is now a reality.
Wittenberg is still practicing! He is not fully committing all his time to Biocurex. That to me is a cardinal sin.
We need a REAL CEO and CFO with expertise in biotech to take us to the next level. I am afraid if it didn't happen by now there is a disconnect between what investors expect and the avenue chosen by the board to get us noticed. It is a total misdirection by the board to continuously throw money at penny newsletters. The amount of "free stock" is almost immediately converted to cash no matter what the share price is at. These people are not interested in investing, and the end result is the share price has been mortally wounded and I can only hope they will learn from their MANY mistakes and will use Terry to properly get us noticed.
Bottom line, we have a stellar scientific board, now it's time to have a managerial board that has the experience and track record to take us out this funk. We have back-peddled over 20% in the past two weeks alone. I am disappointed that we had no follow up from Dr Moro as to how Recaf was received at the meeting. He must also attend more cancer seminars and make himself heard. The share price to me is a report card and in my view they are getting a failing grade. I believe in the science, but they are definitely doing something wrong to promote it.
It appears from the presentation at the ISOBM that 2 important things happened which signal to me that they are ready to demonstrate to the FDA that RECAF is ready. First, was data collected by Biocurex as well as independant data from Abbott in collaboration with samples from Munich. Second, was the accuracy attainable with multiple serum collection tubes meaning it is equally proficient on most other analyzers. With all this data collected over a 2 year period I would think it is sufficient to apply whichever way is deemed required by FDA standards. You may be correct in assessing that there may not be a predicate for a 510(k). This is unique and that is what will propel us from obscurity. My point is that Abbott is well rehearsed along the lines of getting the proper registration and approval, but there is enough data to apply now. There are no more trials necessary, so what is the hold up? I know that Dr Moro is careful not to cause any turbulence with Abbott, so he will not jeopardize his relationship with them. Abbott is a goliath and probably the best partner we could have hoped for in terms of worldwide distribution. The laws in the US are significantly different than in other countries, so maybe we'll see a launch outside the US first. All I want to see is a royalty payment and some revenue to legitimize this entire operation. I am at peace with the fact that this is now a sound investment, unlike earlier this year when no one knew what was happening at Abbott and how this would effect the relationship or progress with RECAF. Now that we know Abbott is definitely on board, but has not yet submitted to the FDA for approval, maybe Dr Moro won't close the deal with another licensee until Abbott is totally committed. He may feel that Abbott is watching closely to see who we are about to license to, so they will not bear the full burden of the FDA approval process alone. If it was an exclusive we would probably see the application already submitted. Obviously, this is just my opinion, but may answer why Abbott is very quiet and secretive. The fact that the last press release was a joint press release was a big deal, but Abbott did not comment to the media or its shareholders on their website about there 96% accuracy of detecting cancer with RECAF.
Gold, is it necessary for a PMA or is the jury still out on the possibility of a 510(k)?
Just one example of GOOD media relations. Look at the multiple television news releases.
Biomarker in the News
Broadcast News
December 11, 2006 - Biomarker Technologies BT Test Featured on Channel 15 News
December 11, 2006 - Biomarker Technologies BT Test Featured on Channel 5 News
May 18, 2006 - Biomarker Technologies BT Test Featured on Channel 3 News
June 10, 2005 - Biomarker Technologies BT Test Featured on Channel 12 News
Home Breast Cancer Facts BT Test
Press Releases
October 19, 2006 - Biomarker Technologies anticipates completion of BT Test™ clinical study
May 1, 2006 - Biomarker Technologies starts clinical study of blood test to diagnose Breast Cancer
Feb 16, 2006 - Clinical Study to Confirm Accuracy of Blood Test for Breast Cancer
May 03, 2005 - Biomarker Technologies New Blood Test Seeks Future Test Candidates
April 27, 2005 - From Research to Revenue - Start-Up Expert to Share Steps to Success
April 19, 2005 - Biomarker Technologies Seeking Series A Funds For Clinical Studies On New Blood Test for Breast Cancer
March 23, 2005 - Biomarker Technologies to Begin Pilot Study Of a New Blood Test for Breast Cancer
March 21, 2005 - Biomarker Technologies Appoints Communications Director
March 10, 2005 - Biomarker Technologies Presenting at Pharma & Biotech Summit
Print News
December 6, 2006 - Blood test in the works to detect breast cancer
November 5, 2006 - Biomarker Technologies Anticipates Completion of BT Test
March 30, 2006 - Accuracy of blood test for breast cancer to be subject of clinical study by Biomarker
March 6, 2006 - New test from Biomarker Technologies assists in early detection for Breast Cancer
March 3, 2006 - Clinical Study to confirm Accuracy of Blood Test for Breast Cancer
March 3, 2006 - Blood Test that Beat Mammogram at Finding Breast Cancer Moves Forward
May 23, 2005 - Biomarker to develop cancer-screening tool
March 04, 2005 - Biomarker featured on LabNews.com
Mysscat, I truly believe that they don't know what to do with it. Abbott doesn't want to shoot themselves in the foot and eliminate other cancer diagnostic tests which in turn would reduce their monetization. There will become a moral issue as to what direction this will go, because we all know that this test alone would eliminate most unnecessary biopsies, surgery as well as therapy. I suggest that Biocurex approach this at a governmental level, speaking with government officials, starting with Canada, and target countries that are practicing socialized medicine. This would be accepted with open arms, and the cost savings to their medical system would be hard to dispute. Then I feel that our country and all others would also be hard-pressed to follow suit.
The board has to close the deal with other licensees soon or we will lose all the momentum garnered by the recent meeting. Abbott has too many other licensing deals to focus soley on us. I am up in arms at the waste of money and the amount of share dilution that is blown on penny stock news letters. I feel it is time to start asking the necessary questions as to why we are still unnoticed at this stage of the game. I propose we all put together a letter FROM THE SHAREHOLDERS to the board of Biocurex and have them address our questions and concerns. We deserve better exposure than penny stock newsletters. Why are they so shy and not at least attempt national media exposure. If they signed another lincensee Abbott is forced to move forward. My single most important question is why are we not presenting at EVERY cancer meeting?
I am not proposing that we attack the board, but the voices of many speak much loader than the voice of one. Let's draft a letter from all who have the best interests for the company at heart and let's continue the momentum. It is unacceptable to me that no one even knows that this technology exists.
I can't sleep!!!! I've waited and invested on the dips over 4 years and finally when I read the news it was the Golden Ticket I've been waiting all these years for. Thanks to Gold when he put the pieces to the puzzle together and enlightened us all I knew we were close, but the true realization will come tommorow. I think we all just got the last remaining number correct on our lottery ticket today and we just have to wait to see what what riches we all are about to receive.
The validation by Abbott will send shock waves at that meeting. It appears Recaf demonstrated accuracy of almost 96%. How impressive is that. Those are results that command attention. These were performed on the Architect analyzer independantly. Remember Dr Moro is done with Abbott and is expanding the lab and hiring additional technicians and will continue to work feverishly to get the rapid point of care test perfected. He will deliver as promised. This is the only UNIVERSAL cancer marker discovered and we have the lead scientists involved with the company. I expect we will be seeing BOCX crossing the ticker on CNBC in the very near future. God Bless Dr Moro for all his endless hours and dedication. Good luck to all from this amazing board. I have always been here hoping to contribute as well as learn from others. There is a long list of contributers, but I just want to give thanks for leaving no stone unturned, from the science down to the management. Thank you all! I expect great things to come out the meeting.
There is going to be alot of people chasing this stock higher realizing how close we are to making the big time. We went to over 4 dollars on preliminary data over 4 years ago, now we likely will be hearing substantiated data, so it is funny seeing people quibble over pennys in the share price today. Next week we will be in another category.
I think the sellers are thinking twice. We will likely see .80 cents by the close. It looks like ask is 2500 @.74, 5000 @ .75 then we jump to .80 cents
risk vs. reward
this is your last chance to dollar cost average into this stock
I agree we are looking at a substantial increase in share price, but the movement will depend soley on how the information is presented to the press and other media. They must express that this is a now a legitimate UNIVERSAL cancer marker which completely sets this apart from any of the other cancer markers. They must present this information as an historic moment for modern medicine and contact the proper sources. If done properly, it will cause a spike that will make what happened 4 years ago (from .40 cents to about 5 dollars on over 20 million shares in one day)look miniscule. I am aware we have a larger float, but IMO anyone selling will be missing out on the big picture.
The speculation will be rampant this weekend about the ISOBM, and exactly when we get our press release, but hopefully Monday will be the target date. When Abbott gives us the green light I trust Terry will use all of his sources to give Biocurex maximum exposure.
Interesting avenue Recaf can also be used for: (Excerpt from previous post)
"In the project announced Tuesday, the FDA, National Cancer Institute and Medicare will collaborate to find better biomarkers for cancer, or better ways to measure and use them.
_____predict very early whether a patient is responding to treatment."
Dr Moro mentioned genetic testing to find out if an individual is predisposed, but it may also be used to see how an individual is responding to treatment.
I have been giving some thought to how best leverage the future press releases after the ISOBM, and I feel that the insurance companies will push hard to have their subscribers tested with Recaf. When the time is right let them know the benefits and cost savings of early detection by encouraging everyone to be tested.
Unrelated to my previous statement, does anyone know if any of the positions have been filled at the lab?
Your email is a year old and at that time Dr Moro had to prioritize his efforts. You seem to forget Abbott was working on the Architect system simultaneously and we would have lost everything if Dr Moro wasn't the one to convert the test over to chemoluminescence.
It also doesn't mean that Goshen wasn't proceeding. If you were the one selling your shares, thank you!
They already applied for AFP. Not recaf, though. Predicate?
P820060/S013
2/2/04
180-Day
Abbott Architect AFP
Abbott Laboratories
Abbott Park, IL
60064
Approval for the addition of the AFP assay on the Architect immunoassay instrument. The device, as modified, will be marketed under the trade name Architect AFP assay and is indicated for the quantitative determination of alpha-fetoprotein (AFP) in :
We are all just speculating. We can agree that we are just beginning to be rewarded and no one can absolutely know how high the share price will go (remember the 1 1/2 year chart on PLX), but the point is that this is an unbelievable opportunity and we will be higher during the next three weeks. I wish the small cap newsletter would stop sending mixed signals. The publisher is annoying. If I may quote Cramer, a great statesman, "YOU KNOW NOTHING!" Their opinion is worthless, because you can't talk out of both sides of your mouth. His lack of patience is what got him in trouble. Fortunately for everyone on this board we have been given a heck of a bronco ride, but we all hung on.